We designed a single-center, open-labelnon-inferiority randomized controlled trial (RCT) to explore whether OCP pretreatment beforethe GnRH antagonist protocol in women with PCOS would improve embryo quality. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.